drugset / Trial / NCT07816562

Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)

NCT07816562 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to compare different ovulation triggering strategies in women with low ovarian reserve undergoing fresh in vitro fertilization (IVF) cycles. Ovulation triggering is a key step in IVF treatment, as it determines final oocyte maturation prior to oocyte retrieval. Participants are randomly assigned to one of three ovulation trigger approaches: human chorionic gonadotropin (hCG) alone, follitropin delta combined with hCG, or dual trigger using a gonadotropin-releasing hormone (GnRH) agonist plus hCG. The primary objective is to evaluate wether adding follitropin delta at the time of triggering increases the number of matura oocytes obtained, without adversely affecting implantation rates. Pregnancy otucomes following fresh embryo transfer will also be assessed. The results of this study may help optimize ovulation triggering strategies in women with low ovarian reserve undergoing IVF treatment.

Timeline

Start
2024-09-17
Primary completion
2027-07-01
Completion
2028-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Follitropin delta Protein / enzyme biologic — —
Subject Human Chorionic Gonadotropin (HCG) Unknown — —
Subject Triptorelin Other / unclassified — —

Indications